We achieve success across all therapeutic areas and target demographics. We have the experience to serve as your next investigative site. Ask us for more information.

 

YearTypeAgeGroupGoalRandomized% of GoalRetention Rate
2014Influenza50+Adult225307135%99%
2014Influenza18 to 49Adult6363100%100%
2014Influenza3 to 17Pediatric302273%100%
2014Pneumococcal50+Elderly201890%89%
2014Norovirus18 to 49Adult5556102%TBD
2014Influenza18 to 40Adult8082103%TBD
2014Meningitis B10 to 19Adolescent2023115%87%
2014Cholera18 to 45Adult100158158%83%
2014Influenza18+Adult7070100%99%
2014Avian Influenza21 to 64Adult4949100%96%
2014Influenza3 to 29Adolescent585595%96%
2013Influenza18+Adult9098109%100%
2013Pneumonia50+Elderly2027135%100%
2013Smallpox18 to 40Adult115196170%100%
2012Influenza65+Elderly180180100%99%
2012Influenza18 to 64Adult8787100%100%
2012HPV16 to 26Young Adult1821117%95%
2012Influenza65+Elderly180180100%99%
2012Pneumococcal50+Elderly2430125%100%
2012Anthrax18 to 65Adult5059118%98%
2011Influenza65+Elderly145180124%99%
2011Meningitis10 to 16Adolescent5057114%89%
2011Meningitis11 to 18Adolescent3044147%93%
2010Influenza65+Elderly6767100%100%
2010HPV (Rescue Site)12 to 26Adolescent301653%94%
2010Tetanus11 to 18Adolescent291862%100%
2010Hepatitis B40 to 70Elderly60125208%100%
2009H1N118+Adult8993104%98%
2009Influenza18 to 64Adult2929100%100%
2009H1N118+Adult16015899%97%
2009H1N118+Adult605592%98%
2009Nasal2 to 17Pediatric201995%95%
2009H1N16M to 9Pediatric302687%99%
2009Nasal18 to 49Adult100100100%98%
2009H1N12 to 17Pediatric2020100%95%
2009Influenza18 to 49Adult100100100%100%
2008Influenza18 to 49Adult144189131%97%
2008Influenza50+Elderly107107100%100%
2008Influenza18 to 64Adult1009999%93%
2008Shingles60+Elderly4375%100%
2008Avian Influenza18 to 45Adult7070100%97%
2008Pneumonia68+Elderly2037185%97%
2008Avian Influenza18+Adult111119107%97%
2007Influenza18 to 49Adult5050100%96%
2007Pneumonia50 to 59Adult3079263%86%
2007Influenza18 to 49Adult1212100%100%
2006Influenza9 to 18Adolescent5074148%74%
2007Influenza6M to 9Pediatric5059118%96%

Need more information? Send us a message here.

At Rochester Clinical Research, we are approaching 50 successful vaccine trials. We’re happy to boast a average enrollment  of goal of 113% and average retention rate of 96%. Almost 3,700 volunteers have randomized into a vaccine trials at RCR. From pediatric to elderly, anthrax to pneumococcal, we continue to have success enrolling volunteers of all ages for all therapeutic areas.

2014 Vaccine Trials

In 2014, we randomized more than 900 volunteers across 11 trials. We’ve averaged a 106% enrollment of our goal. And our retention rates are on track to deliver the quality data our sponsors have asked of us.

2014 Vaccine Trials: Goal vs. Randomized

 Vaccine Trial History by Age Group

2014 Vaccine Trial Performance Statistics

YearTypeAgeGroupGoalRandomized% of GoalRetention Rate
2014Influenza50+Adult225307135%99%
2014Influenza18 to 49Adult6363100%100%
2014Influenza3 to 17Pediatric302273%100%
2014Pneumococcal50+Elderly201890%89%
2014Norovirus18 to 49Adult5556102%TBD
2014Influenza18 to 40Adult8082103%TBD
2014Meningitis B10 to 19Adolescent2023115%87%
2014Cholera18 to 45Adult100158158%83%
2014Influenza18+Adult7070100%99%
2014Avian Influenza21 to 64Adult4949100%96%
2014Influenza3 to 29Adolescent585595%96%

See our Complete Vaccine Trial Statistics here.